Month: March 2026

XORTX Announces Change of Effective Date of Share Consolidation

Written by Customer Service on March 26, 2026. Posted in Public Companies.

CALGARY, Alberta, March 26, 2026 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that, further to its news release of March 25, 2026, the Company has delayed the implementation of its share consolidation on the basis of one (1) new common share for every five (5) old common shares (the “Consolidation”) from March 27, 2026 to April 6, 2026, and remains subject to the receipt of all required approvals of the TSX Venture Exchange and Nasdaq Stock Exchange. About XORTX Therapeutics Inc. XORTX is a pharmaceutical company with three clinically advanced products in development: 1) our lead program XRx-026 program for the treatment...

Proposed Merger Approved by Shareholders of CVB Financial Corp. and Shareholders of Heritage Commerce Corp.

Written by Customer Service on March 26, 2026. Posted in Mergers And Acquisitions.

ONTARIO, Calif. and SAN JOSE, Calif., March 26, 2026 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF), the holding company for Citizens Business Bank, and Heritage Commerce Corp (NASDAQ: HTBK), the holding company for Heritage Bank of Commerce, today jointly announced that each company’s respective shareholders have voted to approve the proposed merger of Heritage Commerce Corp with and into CVB Financial Corp. Subject to the receipt of regulatory approvals and satisfaction of all remaining closing conditions set forth in the merger agreement, the parties anticipate consummating the merger in the second quarter of 2026. About CVB Financial Corp. CVB Financial Corp. (“CVBF”) is the publicly traded holding company for Citizens Business Bank, National Association. CVBF is one of the 10 largest bank holding companies headquartered...

Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates

Written by Customer Service on March 26, 2026. Posted in Earnings Releases And Operating Results.

Company Demonstrates Clinical Validation and Early Commercial Traction Toward 2026 Revenue Scale RA’ANANA, Israel, March 26, 2026 (GLOBE NEWSWIRE) — Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (“Inspira” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced its financial results for the full year ended December 31, 2025, and provided a corporate update. Dagi Ben-Noon, Chief Executive Officer of Inspira, commented: “2025 marked a pivotal year for Inspira as we advanced from clinical validation into early commercial execution. Throughout 2025 and since year-end, we saw meaningful progress across multiple commercialization pathways for the INSPIRA™ ART100 system, including active clinical use at leading medical centers, advancement of...

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Written by Customer Service on March 26, 2026. Posted in Earnings Releases And Operating Results.

Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide implant advance NPM-139, miniature, ultra long-acting semaglutide implant under development for chronic weight management toward a Phase 1 clinical study with results anticipated by the end of 2026. Single preclinical administration of semaglutide implant configuration demonstrates continued semaglutide exposure and >20% sham-adjusted weight loss for a full year. Solid cash position from multiple recent financings will support operations into mid-2027 and enable the projected completion of key milestones including the Phase 1 study of NPM-139. ALAMEDA, Calif., March 26, 2026 (GLOBE NEWSWIRE) — Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing...

NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

Written by Customer Service on March 26, 2026. Posted in Earnings Releases And Operating Results.

Conference call and webcast scheduled for Wednesday, April 1st, 2026, at 8:00 am EDT / 2:00 pm CEST PARIS and CAMBRIDGE, Mass., March 26, 2026 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 31st, 2026, after the close of the U.S. market. This release will be followed by a conference call and webcast on Wednesday, April 1st, 2026, at 8:00 AM EDT / 2:00 PM CEST, prior to the open of the U.S. market. During the call, Laurent Levy, chief executive officer, and Bart van Rhijn, chief financial and...

AmpliTech Group Reports Fiscal Year 2025 Results With 165% Revenue Growth and Strategic Expansion Into 5G Infrastructure

Written by Customer Service on March 26, 2026. Posted in Earnings Releases And Operating Results.

HAUPPAUGE, N.Y., March 26, 2026 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (NASDAQ: AMPG) today reported financial results for the fiscal year ended December 31, 2025, as included in its Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission. Strong Revenue Growth Driven by 5G and Core RF Product Demand Revenue increased to $25.2 million for fiscal year 2025, compared to $9.5 million in fiscal year 2024, representing growth of approximately 165% year-over-year. The increase was driven primarily by higher sales of low noise amplifier (LNA) and low noise block (LNB) products, expanded 5G product lines, and strong demand from telecommunications and satellite communications customers. The Spectrum division also benefited from a rebound in Asian markets. Gross Profit Expansion Reflects Strategic 5G Market Penetration Gross...

Xos Delivers Third Consecutive Quarter of Positive Operating and Free Cash Flow, Accelerates Platform Expansion Across Vehicles, Powertrains, and Energy Storage

Written by Customer Service on March 26, 2026. Posted in Earnings Releases And Operating Results.

Delivered first production powertrains for Blue Bird school buses Achieved third consecutive quarter of positive operating cash flow and free cash flow, ending 2025 with $14.0 million in cash — up 28% year-over-year Reduced full-year operating expenses by $14.0 million (28.2% YoY) and cut full-year EBITDA loss by more than half — from $42.2 million to $21.0 million LOS ANGELES, March 26, 2026 (GLOBE NEWSWIRE) — Xos, Inc. (NASDAQ: XOS) (“Xos” or the “Company”), a leading energy storage and fleet electrification solutions provider, today reported financial results for the fourth quarter and full year ended December 31, 2025. Building on a year of disciplined execution and consistent operational improvement, Xos closed 2025 with its third consecutive quarter of positive operating cash flow and positive free...

Vroom Announces Fourth Quarter and Full Year 2025 Results

Written by Customer Service on March 26, 2026. Posted in Earnings Releases And Operating Results.

$116.6 million stockholders’ equity as of December 31, 2025 NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) — Vroom, Inc. (Nasdaq:VRM) today announced financial results for the fourth quarter and fiscal year ended December 31, 2025. HIGHLIGHTS OF FOURTH QUARTER AND FULL YEAR 2025$116.6 million stockholders’ equity as of December 31, 2025 and $104.2 million tangible book value(1) as of December 31, 2025 $129.3 million improvement in net loss and $66.0 million improvement in adjusted net loss(2) for full year 2025 compared to 2024 $48.7 million consolidated total available liquidity(3) as of December 31, 2025, consisting of:$10.4 million cash and cash equivalents $11.3 million of liquidity available to UACC under the warehouse credit facilities $27.0 million of available liquidity from delayed draw facility, further...

Xanadu Quantum Technologies Limited Announces Closing of Business Combination with Crane Harbor Acquisition Corp. and Xanadu Quantum Technologies Inc.

Written by Customer Service on March 26, 2026. Posted in Mergers And Acquisitions.

Xanadu to become the first publicly listed pure play photonic quantum computing company and will begin trading on the Nasdaq and Toronto Stock Exchange under the ticker symbol “XNDU” on March 27, 2026 TORONTO, March 26, 2026 (GLOBE NEWSWIRE) — Xanadu Quantum Technologies Limited (“Xanadu” or the “Company”), a leading photonic quantum computing company, today announced the successful completion of its previously announced business combination with Crane Harbor Acquisition Corp. (Nasdaq: CHAC), a publicly traded special purpose acquisition company, and Xanadu Quantum Technologies Inc. (“Old Xanadu”) and US$275 million PIPE financing (the “PIPE Financing”). The Class B Subordinate Voting Shares of Xanadu are expected to trade on Nasdaq and the Toronto Stock Exchange under the ticker symbol “XNDU” starting on March 27, 2026. Xanadu...

Rapid7 Acquires Kenzo Security to Accelerate Preemptive, AI-Powered Security Operations

Written by Customer Service on March 26, 2026. Posted in Mergers And Acquisitions.

Acquisition expands Rapid7’s Command Platform to deliver scalable, machine-speed detection and response that disrupts attackers BOSTON, March 26, 2026 (GLOBE NEWSWIRE) — Rapid7, Inc. (NASDAQ: RPD), a global leader in AI-powered managed cybersecurity operations, announced it has acquired Kenzo Security, an agentic AI security platform built to scale autonomous security investigations. The acquisition further enhances the Rapid7 Command Platform, accelerating industry-leading managed detection and response (MDR) services from AI-assisted workflows to AI-driven, machine-speed security operations. Today, most security operations are only able to investigate a fraction of the alerts their environments generate. Scale limitations keep organizations in reactive mode against attackers: manually investigating high and critical signals across...

Month: March 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals